Golden State Equity Partners - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.

Quarter-by-quarter ownership
Golden State Equity Partners ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$745,500
+36.2%
50,0000.0%0.21%
+35.1%
Q2 2023$547,500
+25.6%
50,0000.0%0.15%
-34.7%
Q1 2023$436,000
+177.7%
50,000
-1.2%
0.24%
+198.7%
Q1 2022$157,000
-8.2%
50,600
+0.2%
0.08%
-8.1%
Q4 2021$171,000
+42.5%
50,500
+53.7%
0.09%
+75.5%
Q3 2021$120,00032,8500.05%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders